Iron Heart
| | |
The medical history of a 59-year-old male, summarized by a selected frame of his most recent angiogram of the heart in a left anterior oblique projection (Figure 1), illustrates the contemporary device armamentarium to fight cardiac disease. Five years ago, the patient had presented to our hospital with dyspnea. The evaluation revealed severe mitral regurgitation caused by a prolapsing posterior leaflet and preserved left ventricular systolic function. Surgical mitral valve reconstruction was performed using a 32 mm annuloplasty ring (AR). In further evolution of his condition, the patient suffered from relapsing presyncope and 9 months later, he underwent resuscitation by defibrillation of ventricular fibrillation. The clinical assessment discovered nonsustained ventricular tachycardia, severely impaired left ventricular function with diffuse hypokinesia, and a nonstenotic plaque in the mid portion of the left anterior descending coronary artery. In light of amiodarone intolerance and paroxysmal atrial flutter/fibrillation, a dual chamber defibrillator system was implanted, featuring atrial and ventricular antitachycardia therapy: right atrial lead (RAL), right ventricular lead (RVL).
Four years later, after two ischemic cerebrovascular strokes, and in light of poorly controlled oral anticoagulation, transcatheter closure of the left atrial appendage (LAA) and the patent foramen ovale (PFO) was performed using a 25 mm (LAA) and a 35 mm (PFO) Amplatzer PFO occluder, respectively. Due to plaque progression, the mid left anterior descending coronary artery was treated by stent (S) implantation during the same session. |
|
| The Journal of Invasive Cardiology - ISSN: 1042-3931 - Volume 18 - Issue 3 (March 2006) - March 2006 - Pages: 134 - 134 | |
|
Create a Successful Vena Cava Filter Practice
Accredited CD
This activity is supported by an educational grant from Cook Incorporated and has been designed for Interventional Cardiologists, Vascular Surgeons, Fellows and Interventional Cardiovascular Nurses and Technologists.
|
| |
|
|
|
|
Achieving Optimal Outcomes in Carotid Stenting: Lessons Learned from Recent Clinical Trials
Complimentary Accredited ON DEMAND Webcast
Topics
1. EVA-3S & Space-Bumps in the road
2. CAPTURE 3500-Lesion morphology & Predictors for Stroke
3. CAPTURE II vs. EXACT 1500-Does open or Closed Cell Stent design really matter?
This activity has been developed for Interventional Cardiologists, Vascular Surgeons, Interventional Radiologists, Neurologists, Interventional Nurses and Technologists with an interest in the diagnosis and treatment of peripheral artery disease. |
|
Anticoagulation Techniques for Peripheral Vascular Interventions
Complimentary Accredited ON DEMAND Webcast
This activity has been developed for Interventional Cardiologists, Vascular Surgeons, Interventional Radiologists, Podiatric Physicians, Endovascular Allied Professionals, Endocrinologists, Wound Care Specialists, Directors of the Wound Care Clinic, and Primary Care Physicians, Pharmacists, Nurses and Technologists.
|
|
|
|
|
|
March 2007 Supplement
|
On-Demand Webcast
|
Archived Webcast
|
|
|
|
|
|
About HMP Communications
HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC, which also owns the North American Center for Continuing Medical Education (NACCME). NACCME provides a wide array of accredited CME offerings with industry thought leaders participating in roundtable meetings, webcasts, symposia, conferences, seminars, podcasts and satellite programs. Discover more about HMP’s products and services at www.hmpcommunications.com. ©2008 HMP Communications |
© 2008 HMP Communications | All Rights Reserved
83 General Warren Blvd, Suite 100 | Malvern, PA 19355 | 800.237.7285
|
|
| | |